| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0083-6729(06)74010-9 |
| P698 | PubMed publication ID | 17027518 |
| P50 | author | Jill M Kramer | Q57545487 |
| P2093 | author name string | Sarah L Gaffen | |
| Fang Shen | |||
| Jeffrey J Yu | |||
| P2860 | cites work | Biology of recently discovered cytokines: interleukin-17--a unique inflammatory cytokine with roles in bone biology and arthritis | Q21195672 |
| Cloning and characterization of IL-17B and IL-17C, two new members of the IL-17 cytokine family | Q22011116 | ||
| Evi27 encodes a novel membrane protein with homology to the IL17 receptor | Q22254100 | ||
| IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL-17Rh1 | Q24290462 | ||
| IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding | Q24291729 | ||
| The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment | Q24323040 | ||
| Molecular characterization of the human interleukin (IL)-17 receptor | Q24336109 | ||
| The role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models | Q24519770 | ||
| CCAAT/enhancer-binding proteins: structure, function and regulation | Q24534323 | ||
| Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells | Q24547568 | ||
| IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis | Q24563235 | ||
| Role of IL-17A, IL-17F, and the IL-17 receptor in regulating growth-related oncogene-alpha and granulocyte colony-stimulating factor in bronchial epithelium: implications for airway inflammation in cystic fibrosis | Q24605366 | ||
| Requirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interleukin 17 signal transduction | Q24676400 | ||
| T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines | Q24678115 | ||
| IL-17 induces production of IL-6 and IL-8 in rheumatoid arthritis synovial fibroblasts via NF-kappaB- and PI3-kinase/Akt-dependent pathways | Q24793443 | ||
| IL-17 markedly up-regulates beta-defensin-2 expression in human airway epithelium via JAK and NF-kappaB signaling pathways | Q46156771 | ||
| IL-17A augments TNF-alpha-induced IL-6 expression in airway smooth muscle by enhancing mRNA stability | Q47913203 | ||
| Interleukin-11 and IL-17 and the pathogenesis of periodontal disease | Q47941847 | ||
| A role of GM-CSF in the accumulation of neutrophils in the airways caused by IL-17 and TNF-alpha. | Q50495241 | ||
| Severe CD4 T cell-mediated immunopathology in murine schistosomiasis is dependent on IL-12p40 and correlates with high levels of IL-17. | Q51989028 | ||
| Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism. | Q52014124 | ||
| Regulation of immune and autoimmune responses by ICOS. | Q53912899 | ||
| Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis. | Q54638927 | ||
| Expression and activity of IL-17 in cutaneous T-cell lymphomas (mycosis fungoides and Sezary syndrome). | Q54706258 | ||
| Interleukin-17 stimulates inducible nitric oxide synthase activation in rodent astrocytes. | Q55473999 | ||
| IL-17 enhances the susceptibility of U-2 OS osteosarcoma cells to NK cell lysis | Q57003139 | ||
| A fork in the pathway to inflammation and arthritis | Q57232046 | ||
| IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand/osteoprotegerin balance | Q64378013 | ||
| Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus | Q73086966 | ||
| Mitogen-activated protein kinase and nuclear factor kappaB together regulate interleukin-17-induced nitric oxide production in human osteoarthritic chondrocytes: possible role of transactivating factor mitogen-activated protein kinase-activated prot | Q73165868 | ||
| T-cell-derived interleukin-17 regulates the level and stability of cyclooxygenase-2 (COX-2) mRNA through restricted activation of the p38 mitogen-activated protein kinase cascade: role of distal sequences in the 3'-untranslated region of COX-2 mRNA | Q73392461 | ||
| High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism | Q73458527 | ||
| Stimulation of 92-kd gelatinase (matrix metalloproteinase 9) production by interleukin-17 in human monocyte/macrophages: a possible role in rheumatoid arthritis | Q73806783 | ||
| Expression of IL-17 mRNA in ovarian cancer | Q74008184 | ||
| CCAAT/enhancer-binding protein delta gene expression is mediated by autoregulation through downstream binding sites | Q74079283 | ||
| Don't count your interleukins before they've hatched | Q74424915 | ||
| Erythropoietin receptor activation by a ligand-induced conformation change | Q78111818 | ||
| Evidence for the involvement of JAK/STAT pathway in the signaling mechanism of interleukin-17 | Q78128202 | ||
| Interleukin-17 promotes angiogenesis and tumor growth | Q78460523 | ||
| Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice | Q79317500 | ||
| T(H)-17: a giant step from T(H)1 and T(H)2 | Q81381452 | ||
| The potential role of interleukin-17 in the immunopathology of periodontal disease | Q81614905 | ||
| A novel interleukin-17 receptor-like protein identified in human umbilical vein endothelial cells antagonizes basic fibroblast growth factor-induced signaling | Q46107500 | ||
| Mithramycin downregulates proinflammatory cytokine-induced matrix metalloproteinase gene expression in articular chondrocytes | Q24817080 | ||
| Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells | Q27860460 | ||
| A novel cytokine receptor-ligand pair. Identification, molecular characterization, and in vivo immunomodulatory activity | Q28119212 | ||
| Interleukin-17 family and IL-17 receptors | Q28185677 | ||
| Transgenic overexpression of human IL-17E results in eosinophilia, B-lymphocyte hyperplasia, and altered antibody production | Q28202510 | ||
| Forced expression of murine IL-17E induces growth retardation, jaundice, a Th2-biased response, and multiorgan inflammation in mice | Q28206221 | ||
| Cutting edge: IL-17D, a novel member of the IL-17 family, stimulates cytokine production and inhibits hemopoiesis | Q28208761 | ||
| IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo | Q28213431 | ||
| Transforming growth factor-beta induces development of the T(H)17 lineage | Q28237370 | ||
| Interleukin-17 family members and inflammation | Q28287876 | ||
| TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells | Q28296956 | ||
| Promotion and attenuation of FGF signaling through the Ras-MAPK pathway | Q28312210 | ||
| Identification of Sef, a novel modulator of FGF signalling | Q28312228 | ||
| New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25 | Q28592257 | ||
| Subnuclear localization of C/EBP beta is regulated by growth hormone and dependent on MAPK | Q28594401 | ||
| Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor | Q28609151 | ||
| IL-23 drives a pathogenic T cell population that induces autoimmune inflammation | Q29547525 | ||
| A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 | Q29547855 | ||
| Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages | Q29547871 | ||
| Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron | Q29619561 | ||
| Increased expression of interleukin 17 in inflammatory bowel disease | Q29622829 | ||
| Increased granulopoiesis through interleukin-17 and granulocyte colony-stimulating factor in leukocyte adhesion molecule-deficient mice | Q30308288 | ||
| Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. | Q30436326 | ||
| Inoculation of human interleukin-17 gene-transfected Meth-A fibrosarcoma cells induces T cell-dependent tumor-specific immunity in mice | Q30693390 | ||
| Interleukin-17/interleukin-17 receptor-mediated signaling is important for generation of an optimal polymorphonuclear response against Toxoplasma gondii infection | Q33556845 | ||
| Cutting edge: roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection. | Q33740453 | ||
| Expression of IL-17 in human memory CD45RO+ T lymphocytes and its regulation by protein kinase A pathway | Q33862141 | ||
| Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis | Q33862720 | ||
| Sequential phosphorylation of CCAAT enhancer-binding protein beta by MAPK and glycogen synthase kinase 3beta is required for adipogenesis | Q33896013 | ||
| A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling | Q33907802 | ||
| Contribution of interleukin 17 to synovium matrix destruction in rheumatoid arthritis | Q33908167 | ||
| Pulmonary interleukin-23 gene delivery increases local T-cell immunity and controls growth of Mycobacterium tuberculosis in the lungs | Q34033850 | ||
| Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense | Q34087551 | ||
| Soluble and transmembrane isoforms of novel interleukin-17 receptor-like protein by RNA splicing and expression in prostate cancer. | Q34101525 | ||
| IL-17 selectively down-regulates TNF-alpha-induced RANTES gene expression in human colonic subepithelial myofibroblasts | Q34143188 | ||
| Interleukin-17 induces src/MAPK cascades activation in human renal epithelial cells | Q34151371 | ||
| Expression and function of pro-inflammatory interleukin IL-17 and IL-17 receptor in normal, benign hyperplastic, and malignant prostate. | Q34200792 | ||
| Evidence for ligand-independent multimerization of the IL-17 receptor | Q34279731 | ||
| IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-gamma responses if IL-12p70 is available | Q34432140 | ||
| Interleukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes. | Q34474419 | ||
| Interleukin-17-induced gene expression in articular chondrocytes is associated with activation of mitogen-activated protein kinases and NF-kappaB. | Q34474493 | ||
| IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6 | Q34521302 | ||
| Cytokine and cytokine receptor pleiotropy and redundancy | Q34693494 | ||
| Chemokines, cytokines and their receptors in Hodgkin's lymphoma cell lines and tissues | Q34700754 | ||
| Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity | Q34945351 | ||
| IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist | Q35022575 | ||
| IL-17-induced cytokine release in human bronchial epithelial cells in vitro: role of mitogen-activated protein (MAP) kinases | Q35043470 | ||
| Neutrophil-mediated tissue injury in periodontal disease pathogenesis: findings from localized aggressive periodontitis | Q35068805 | ||
| Interleukin-17 in rheumatoid arthritis: if T cells were to contribute to inflammation and destruction through synergy | Q35083970 | ||
| The STIR-domain superfamily in signal transduction, development and immunity | Q35135588 | ||
| Interleukin 17 synergises with tumour necrosis factor alpha to induce cartilage destruction in vitro | Q35551055 | ||
| Inducible nitric oxide synthase activation by interleukin-17. | Q35640431 | ||
| The roles of CARMA1, Bcl10, and MALT1 in antigen receptor signaling | Q35947710 | ||
| Neutrophils, interleukin-17A and lung disease | Q36003968 | ||
| Prototypic T cell receptor and CD4-like coreceptor are expressed by lymphocytes in the agnathan sea lamprey | Q37513290 | ||
| Cytokines link osteoblasts and inflammation: microarray analysis of interleukin-17- and TNF-alpha-induced genes in bone cells | Q38333262 | ||
| The interleukin-17 gene of herpesvirus saimiri. | Q39582413 | ||
| Interleukin-17 stimulates inducible nitric oxide synthase-dependent toxicity in mouse beta cells. | Q40356004 | ||
| IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis | Q40360012 | ||
| Interleukin-17 regulates expression of the CXC chemokine LIX/CXCL5 in osteoblasts: implications for inflammation and neutrophil recruitment | Q40563240 | ||
| Interleukin (IL)-17 enhances tumor necrosis factor-alpha-stimulated IL-6 synthesis via p38 mitogen-activated protein kinase in osteoblasts | Q40575542 | ||
| Functional Cooperation between Interleukin-17 and Tumor Necrosis Factor-α Is Mediated by CCAAT/Enhancer-binding Protein Family Members | Q40619563 | ||
| hSef inhibits PC-12 cell differentiation by interfering with Ras-mitogen-activated protein kinase MAPK signaling. | Q40637291 | ||
| IL-17 expression in human herpetic stromal keratitis: modulatory effects on chemokine production by corneal fibroblasts. | Q40691425 | ||
| STAT1 is required for iNOS activation, but not IL-6 production in murine fibroblasts | Q40830150 | ||
| Induction of NF-kappaB by the Akt/PKB kinase | Q40950127 | ||
| CD40 signaling through tumor necrosis factor receptor-associated factors (TRAFs). Binding site specificity and activation of downstream pathways by distinct TRAFs | Q40955336 | ||
| Interleukin 17 induces cartilage collagen breakdown: novel synergistic effects in combination with proinflammatory cytokines | Q41866942 | ||
| Increased matrix metalloproteinase-9 concentration and activity after stimulation with interleukin-17 in mouse airways. | Q42264569 | ||
| Interleukin-17: A new bone acting cytokine in vitro | Q42476956 | ||
| Interleukin-1, tumor necrosis factor alpha, and interleukin-17 synergistically up-regulate nitric oxide and prostaglandin E2 production in explants of human osteoarthritic knee menisci | Q42511137 | ||
| Compromised humoral and delayed-type hypersensitivity responses in IL-23-deficient mice | Q42620442 | ||
| IL-12- and IL-23-induced T helper cell subsets: birds of the same feather flock together | Q42972111 | ||
| IL-6 secretion by human pancreatic periacinar myofibroblasts in response to inflammatory mediators | Q43845883 | ||
| IL-17 stimulates inflammatory responses via NF-kappaB and MAP kinase pathways in human colonic myofibroblasts | Q43997188 | ||
| Down-regulation of proinflammatory capacity during apoptosis in human polymorphonuclear leukocytes | Q44355424 | ||
| Matrix metalloproteinase-3 secretion from human colonic subepithelial myofibroblasts: role of interleukin-17. | Q44490498 | ||
| Crucial role for nuclear factor of activated T cells in T cell receptor-mediated regulation of human interleukin-17. | Q45086536 | ||
| Triptolide suppresses proinflammatory cytokine-induced matrix metalloproteinase and aggrecanase-1 gene expression in chondrocytes | Q45209550 | ||
| Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice | Q45876568 | ||
| Requirement of IL-17 receptor signaling in radiation-resistant cells in the joint for full progression of destructive synovitis | Q45886163 | ||
| P304 | page(s) | 255-282 | |
| P577 | publication date | 2006-01-01 | |
| P1433 | published in | Vitamins and Hormones | Q15753296 |
| P1476 | title | The IL-17 cytokine family | |
| P478 | volume | 74 |
| Q37249268 | A new inflammatory cytokine on the block: re-thinking periodontal disease and the Th1/Th2 paradigm in the context of Th17 cells and IL-17. |
| Q91964992 | A single bacterium restores the microbiome dysbiosis to protect bones from destruction in a rat model of rheumatoid arthritis |
| Q24679426 | APC-derived cytokines and T cell polarization in autoimmune inflammation |
| Q36625070 | An Immunoprotective Privilege of Corneal Epithelial Stem Cells Against Th17 Inflammatory Stress by Producing Glial Cell-Derived Neurotrophic Factor |
| Q35804523 | An essential role for IL-17 in preventing pathogen-initiated bone destruction: recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals |
| Q47727612 | Anti-IL-23 and Anti-IL-17 Biologic Agents for the Treatment of Immune-Mediated Inflammatory Conditions |
| Q50089437 | Association of Interleukin-6 and Other Cytokines with Self-Reported Pain in Prostate Cancer Patients Receiving Chemotherapy |
| Q38134125 | Bacteria take control of tolls and T cells to destruct jaw bone. |
| Q35769049 | Cells of the synovium in rheumatoid arthritis. T lymphocytes. |
| Q42254658 | Cellular interplay among Th17, Th1, and Treg cells in HIV-1 subtype "C" infection |
| Q34983853 | Characterization of phenotypes of immune cells and cytokines associated with chronic exposure to Premolis semirufa caterpillar bristles extract |
| Q37047867 | Chronic pediatric inflammatory diseases: effects on bone |
| Q37772085 | Combination of intensive chemotherapy and anticancer vaccines in the treatment of human malignancies: the hematological experience |
| Q97523981 | Copy number variation of IL17RA gene and its association with the ankylosing spondylitis risk in Iranian patients: a case-control study |
| Q39249606 | Critical role of interleukin-17A in murine intestinal ischemia-reperfusion injury |
| Q34348129 | Cytokines induce small intestine and liver injury after renal ischemia or nephrectomy |
| Q38291870 | Differential regulation of the IL-17 receptor by gammac cytokines: inhibitory signaling by the phosphatidylinositol 3-kinase pathway. |
| Q36571575 | Distinct regulation of interleukin-17 in human T helper lymphocytes |
| Q33955912 | Emerging role of IL-17 in atherosclerosis |
| Q26768254 | Enigma of IL-17 and Th17 Cells in Rheumatoid Arthritis and in Autoimmune Animal Models of Arthritis |
| Q58684814 | Genetic polymorphisms of IL-17A rs2275913, rs3748067 and IL-17F rs763780 in gastric cancer risk: evidence from 8124 cases and 9873 controls |
| Q36360708 | Heterogeneity of EAE mediated by multiple distinct T-effector subsets |
| Q37842628 | How has neutrophil research improved our understanding of periodontal pathogenesis? |
| Q34415214 | Hypothyroidism in Noninterferon Treated-HCV Infected Individuals Is Associated with Abnormalities in the Regulation of Th17 Cells |
| Q34401701 | IL-17 regulates adipogenesis, glucose homeostasis, and obesity |
| Q35671394 | IL-17 signaling in host defense against Candida albicans |
| Q38111443 | IL-17 targeted therapies for psoriasis |
| Q30435495 | IL-17A controls IL-17F production and maintains blood neutrophil counts in mice |
| Q36641593 | Interleukin-17 causes Rho-kinase-mediated endothelial dysfunction and hypertension |
| Q89479730 | Interleukin-17A Exacerbates Disease Severity in BALB/c Mice Susceptible to Lung Infection with Mycoplasma pulmonis |
| Q52902894 | Interleukin-17A promotes IgE production in human B cells. |
| Q55069382 | Intestinal neuroendocrine cells and goblet cells are mediators of IL-17A-amplified epithelial IL-17C production in human inflammatory bowel disease. |
| Q52922958 | Natural killer T-cell characterization through gene expression profiling: an account of versatility bridging T helper type 1 (Th1), Th2 and Th17 immune responses. |
| Q24316237 | Negative regulation of IL-17 production by OX40/OX40L interaction |
| Q54310492 | Overexpression and Potential Regulatory Role of IL-17F in Pathogenesis of Chronic Periodontitis. |
| Q33832522 | Paneth cell-derived interleukin-17A causes multiorgan dysfunction after hepatic ischemia and reperfusion injury |
| Q36417320 | Paneth cell-mediated multiorgan dysfunction after acute kidney injury |
| Q92434479 | Psoriasis: Association of interleukin-17 gene polymorphisms with severity and response to treatment |
| Q38190986 | Role of IL-23 in the pathogenesis of psoriasis: a novel potential therapeutic target? |
| Q48278167 | Scanning the Immunopathogenesis of Psoriasis |
| Q38777116 | Secukinumab (AIN457) in the treatment of ankylosing spondylitis |
| Q28066204 | Secukinumab: A New Treatment Option for Psoriatic Arthritis |
| Q36584981 | Spinal interleukin-17 promotes thermal hyperalgesia and NMDA NR1 phosphorylation in an inflammatory pain rat model. |
| Q24648045 | Structure and signalling in the IL-17 receptor family |
| Q37051768 | Structure-function relationships in the IL-17 receptor: implications for signal transduction and therapy |
| Q35059071 | TLR2 signaling and Th2 responses drive Tannerella forsythia-induced periodontal bone loss. |
| Q27026324 | Targeting of interleukin-17 in the treatment of psoriasis |
| Q34565713 | Th17 cells can provide B cell help in autoantibody induced arthritis |
| Q37049058 | Th17 cells: a new fate for differentiating helper T cells |
| Q49678810 | The IL-17B-IL-17 receptor B pathway promotes resistance to paclitaxel in breast tumors through activation of the ERK1/2 pathway. |
| Q37070709 | The adaptor protein CIKS/Act1 is essential for IL-25-mediated allergic airway inflammation |
| Q36845302 | The interleukin-17 receptor plays a gender-dependent role in host protection against Porphyromonas gingivalis-induced periodontal bone loss |
| Q38217029 | The role of interleukin-17A in psoriatic disease |
| Q38098466 | Therapeutic strategies in psoriasis patients with psoriatic arthritis: focus on new agents |
| Q33707467 | Trypanosomiasis-induced Th17-like immune responses in carp. |
| Q38334718 | Tumor necrosis factor α-mediated induction of interleukin 17C in human keratinocytes is controlled by nuclear factor κB. |
| Q36445919 | Update on psoriasis immunopathogenesis and targeted immunotherapy. |
Search more.